Study to Evaluate the Safety of SP-104

Clinical trial NCT04958876 · COMPLETED

Trial details

NCT number: NCT04958876
Sponsor: Scilex Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2021-10-04
Primary completion: 2021-12-20
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.